Ferlenga P, Morazzoni G, Da Ros B, Branca E, Fantoni M, Marchini F, Pocchiari F, Semeraro C
Research and Development Division, Zambon Group, Bresso Milan, Italy.
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S78-80.
We have characterized the endothelin-converting enzyme (ECE)-like activity involved in big endothelin (ET)-1-induced contraction in rabbit saphenous artery (RSA). Big ET-1 30 nM caused a contraction that was independent of the vascular endothelium. Phosphoramidon and the neutral endopeptidase (NEP) inhibitors thiorphan and candoxatrilat blocked the vasoconstriction caused by big ET-1 in endothelium-denuded RSA. Candoxatrilat (IC50 17 nM) and thiorphan (IC50 2.5 nM), were 5- to 30-fold more potent than phosphoramidon (IC50 83 nM). Other protease inhibitors were inactive. In cultured endothelial cells the ET-1 release was inhibited only by phosphoramidon (IC50 16 microM) but at a concentration 200-fold that required an endothelium-denuded RSA. In conclusion, we can speculate that the big ET-1 contraction in RSA is mediated by an ECE, probably present on smooth muscle cells, which is susceptible to NEP inhibitors and is different from the ECE on endothelial cells.
我们已经对参与大内皮素(ET)-1诱导的兔隐动脉(RSA)收缩的内皮素转换酶(ECE)样活性进行了表征。30 nM的大ET-1引起的收缩与血管内皮无关。磷酰胺脒以及中性内肽酶(NEP)抑制剂噻吗洛尔和坎多沙坦酯可阻断去内皮RSA中由大ET-1引起的血管收缩。坎多沙坦酯(IC50为17 nM)和噻吗洛尔(IC50为2.5 nM)的效力比磷酰胺脒(IC50为83 nM)强5至30倍。其他蛋白酶抑制剂无活性。在培养的内皮细胞中,ET-1的释放仅受磷酰胺脒抑制(IC50为16 μM),但其浓度是去内皮RSA所需浓度的200倍。总之,我们可以推测,RSA中的大ET-1收缩是由一种可能存在于平滑肌细胞上的ECE介导的,该ECE对NEP抑制剂敏感,且与内皮细胞上的ECE不同。